MilliporeSigma adds first non-mammalian cell line to portfolio
MilliporeSigma collaborates with GlycoBac to provide an Sf-9 insect cell line for vaccine and gene therapy development.
Archives for October 24, 2018
AstraZeneca bolsters immuno-oncology pipeline with $242m Innate stake
AstraZeneca buys a 9.8% stake and takes up option to acquire full rights for monalizumab from Innate Pharma.